Empower Advisory Group, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 1978885
Greenwood Village, CO
Position in HALO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$250,855
+$36,930 QoQ
Shares Held
3,205
-3.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#481
of 664 holders
Holding Since
Mar 2023
14 quarters on record
Common Shares in HALO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empower Advisory Group, LLC holds $509,651 across 2 Biotechnology names. HALO ranks #2 (49.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
521 | $258,796 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
This page
|
3,205 | $250,855 |
All Filings in HALO
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,855 | 3,205 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $213,925 | 3,310 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $553,071 | 8,218 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $301,354 | 4,109 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $231,489 | 4,450 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $283,954 | 4,450 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $272,851 | 5,707 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $326,668 | 5,707 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $307,248 | 5,868 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $238,710 | 5,868 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $273,023 | 7,387 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $282,183 | 7,387 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $266,449 | 7,387 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $282,109 | 7,387 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||